PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S.
Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14.
Plasmablastic lymphoma: An update.
Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ.
Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):54-63. doi: 10.1111/ijlh.13863.
Extranodal T- and NK-cell lymphomas.
de Leval L, Feldman AL, Pileri S, Nakamura S, Gaulard P.
Virchows Arch. 2023 Jan;482(1):245-264. doi: 10.1007/s00428-022-03434-0. Epub 2022 Nov 7.
A single-cell atlas of diffuse large B cell lymphoma.
Ye X, Wang L, Nie M, Wang Y, Dong S, Ren W, Li G, Li ZM, Wu K, Pan-Hammarström Q.
Cell Rep. 2022 Apr 19;39(3):110713. doi: 10.1016/j.celrep.2022.110713.
Senescence-associated reprogramming promotes cancer stemness.
Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, Mendoza-Parra MA, Kanashova T, Metzner M, Pardon K, Reimann M, Trumpp A, Dörken B, Zuber J, Gronemeyer H, Hummel M, Dittmar G, Lee S, Schmitt CA.
Nature. 2018 Jan 4;553(7686):96-100. doi: 10.1038/nature25167. Epub 2017 Dec 20.
New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES.
Virchows Arch. 2023 Jan;482(1):227-244. doi: 10.1007/s00428-022-03414-4. Epub 2022 Oct 11.
Update on the therapy of highly aggressive non-Hodgkin's lymphoma.
Jacobsen E, LaCasce A.
Expert Opin Biol Ther. 2006 Jul;6(7):699-708. doi: 10.1517/14712598.6.7.699.
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.
Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, Doane AS, Venters BJ, Portillo-Ledesma S, Conway J, Phillip JM, Elemento O, Scott DW, Béguelin W, Licht JD, Kelleher NL, Staudt LM, Skoultchi AI, Keogh MC, Apostolou E, Mason CE, Imielinski M, Schlick T, David Y, Tsirigos A, Allis CD, Soshnev AA, Cesarman E, Melnick AM.
Nature. 2021 Jan;589(7841):299-305. doi: 10.1038/s41586-020-3017-y. Epub 2020 Dec 9.
Highly aggressive lymphomas in adults.
Sweetenham JW.
Hematol Oncol Clin North Am. 2008 Oct;22(5):965-78, ix. doi: 10.1016/j.hoc.2008.07.009.
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights.
Ali A, Goy A, Dunleavy K.
Blood. 2022 Sep 29;140(13):1461-1469. doi: 10.1182/blood.2022016226.
